Physician

Betsy Perry Backe, M.D.

According to 2025 Medicare claims, Betsy Backe, M.D. (NPI: 1457554131) practices dermatology in the Valdosta, GA market, with the plurality of this provider's patient population coming from Lowndes, GA. This provider's primary affiliated billing organization is THACKER DERMATOLOGY LLC (NPI: 1326347238; TIN: 27-4374192) and primary practice location at 31602-6926.

Backe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 874 traditional Medicare patients, billed 58,413 HCPCS/CPT codes, and received $877,897 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,103 prescription claims across 374 beneficiaries totaling $1,410,211 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 99 records totaling $2,274. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $249,863 to $1,410,211. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,376	12,506	$569,430
2016	1,615	14,925	$651,710
2017	1,828	17,450	$762,146
2018	2,165	106,490	$952,392
2019	2,169	87,868	$848,124
2020	1,942	72,173	$790,114
2021	1,706	51,759	$828,882
2022	1,625	57,112	$890,238
2023	916	81,392	$753,142
2024	874	58,413	$877,897

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	554	1,418	$249,863
2016	571	1,717	$342,108
2017	725	1,990	$255,135
2018	697	1,912	$321,494
2019	389	927	$288,551
2020	322	771	$602,741
2021	260	712	$371,845
2022	284	706	$658,930
2023	347	926	$1,233,483
2024	374	1,103	$1,410,211

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	279	388	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	435	762	$59
11102	Biopsy of related skin growth, first growth	213	254	$53
17000	Destruction of precancer skin growth, 1 growth	383	494	$31
17003	Destruction of precancer skin growth, 2-14 growths	295	1,690	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	15	700	$225,422
Dupixent Pen	Dupilumab	56	1,680	$223,548
Tremfya	Guselkumab	16	896	$208,002
Remicade	Infliximab	12	336	$198,693
Enbrel Sureclick	Etanercept	12	336	$87,144

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	99	$2,274	Biofrontera Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Betsy Perry Backe, M.D.?

Tedicare shows public-source Medicare data for Betsy Perry Backe, M.D. (NPI 1457554131), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Betsy Perry Backe, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Betsy Perry Backe, M.D.?

Betsy Perry Backe, M.D. is linked to THACKER DERMATOLOGY LLC (billing NPI 1326347238) in the available physician profile data.

Does Betsy Perry Backe, M.D. have Open Payments data?

Betsy Perry Backe, M.D. has 99 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.